Labcorp
About: Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Employees: 70,000
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
120% more first-time investments, than exits
New positions opened: 112 | Existing positions closed: 51
44% more funds holding in top 10
Funds holding in top 10: 9 [Q4 2024] → 13 (+4) [Q1 2025]
5% more funds holding
Funds holding: 908 [Q4 2024] → 951 (+43) [Q1 2025]
0% less capital invested
Capital invested by funds: $17.9B [Q4 2024] → $17.8B (-$29.4M) [Q1 2025]
6% less repeat investments, than reductions
Existing positions increased: 327 | Existing positions reduced: 347
10% less call options, than puts
Call options by funds: $41.8M | Put options by funds: $46.2M
1.48% less ownership
Funds ownership: 93.03% [Q4 2024] → 91.54% (-1.48%) [Q1 2025]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$250
4%
downside
Avg. target
$274
5%
upside
High target
$290
11%
upside
6 analyst ratings
4 positive
67%
2 neutral
33%
0 negative
0%
Morgan Stanley Ricky Goldwasser | 8%upside $283 | Overweight Maintained | 11 Jun 2025 |
Truist Securities David Macdonald | 11%upside $290 | Buy Maintained | 12 May 2025 |
Piper Sandler David Westenberg | 7%upside $280 | Neutral Maintained | 6 May 2025 |
Barclays Jack Meehan | 4%downside $250 | Equal-Weight Maintained | 30 Apr 2025 |
Baird Eric Coldwell | 2%upside $267 | Outperform Maintained | 30 Apr 2025 |
Financial journalist opinion
Based on 8 articles about LH published over the past 30 days
Positive
Zacks Investment Research
1 week ago
Should You Continue to Hold Labcorp Stock in Your Portfolio?
Labcorp Holdings Inc. LH, or Labcorp's strong focus on key areas such as oncology, women's health, autoimmune disease and neurology is poised to help it grow in the upcoming quarters. The company maintains a steady pipeline of potential deals that support its financial strategy and will enhance its organic growth.
Positive
Zacks Investment Research
1 week ago
LH Stock Rises Following the Expansion of Precision Oncology Portfolio
Labcorp expands its precision oncology lineup with new cancer tests and a global diagnostic tool.
Neutral
GlobeNewsWire
1 week ago
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- InStride , a leading provider of strategic education and skilling solutions, has facilitated a unique partnership between Arizona State University's College of Health Solutions and Labcorp, a global leader of innovative and comprehensive laboratory services, to launch a Master of Science in Cytology. ASU's online graduate program addresses the severe shortage of cytotechnologists—specialists essential to cancer detection and diagnostics.
Neutral
PRNewsWire
2 weeks ago
Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research
New test offerings target solid tumors and hematologic malignancies Enhanced biopharma services support accelerated clinical trials and companion diagnostic development BURLINGTON, N.C. , May 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio.
Positive
Zacks Investment Research
2 weeks ago
Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report?
Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Neutral
Zacks Investment Research
2 weeks ago
LH or SAUHY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Labcorp (LH) or Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?
Positive
Zacks Investment Research
2 weeks ago
Are Investors Undervaluing Labcorp (LH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Positive
Zacks Investment Research
3 weeks ago
Here's Why Labcorp (LH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Positive
Zacks Investment Research
1 month ago
Here's Why Labcorp (LH) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Positive
Zacks Investment Research
1 month ago
3 Dental Supplies Stocks Likely to Gain From US-China Trade Deal
Here we discuss three stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, LH and ALGN.
Charts implemented using Lightweight Charts™